Medication info
Sitauni Tablet 25 mg (Sitagliptin Hydrochloride Monohydrate)

Sitauni Tablet 25 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Korea Union Pharmaceutical Co., Ltd.
Appearance
Pink, round, biconvex film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP×3)]
Approval status
Active

MFDS item code 202100085 · Approved 2021.01.06 · Insurance code 665508310

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at a dose of 100 mg once daily when used as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Since dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Korea Union Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used to assist in the dietary management and exercise regimen for improving blood sugar control in patients with type 2 diabetes. It can be initiated as a monotherapy and, in cases where no prior diabetes medication therapy has been administered or where blood sugar control is difficult with monotherapy, it may be used in conjunction with Metformin. Additionally, it is combined with sulfonylureas, Metformin, thiazolidinediones, insulin, and other monotherapy medications to enhance therapeutic effects when blood sugar control is difficult. This medication can also be added to treatment when blood sugar control is insufficient despite combination therapy. Thus, it supports blood sugar management at various treatment stages and enhances overall blood sugar control.

How to take

Adult dose

This medicine is administered at a dose of 100 mg once daily when used as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Since dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause serious allergic reactions, and if symptoms such as skin rash or difficulty breathing occur, the patient should stop taking it immediately and consult a doctor. During the use of this medication, pancreatitis, an inflammation of the pancreas, can occur. Therefore, if symptoms such as abdominal pain, vomiting, or loss of appetite arise, a hospital visit is necessary. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis, and those allergic to this medication or its components should also avoid it. Patients with impaired kidney function may need to adjust the dosage of this medication and undergo regular kidney function tests. There is a risk of hypoglycemia when taking this medication, especially if used with insulin or sulfonylureas. Therefore, careful monitoring of blood sugar levels should be conducted, and dosage adjustments may be necessary. Rarely, side effects such as arthralgia or skin vesicles have been reported, so a doctor should be consulted if such symptoms appear. Pregnant or breastfeeding women should avoid taking this medication, and its safety has not been established for children or adolescents under 18 years old. Elderly patients may experience a decline in kidney function, so evaluating kidney function before use and adjusting the dosage may be necessary. In case of overdose, symptomatic treatment such as removing the medication from the gastrointestinal tract should be performed, and hemodialysis may be considered as it can remove some of the drug. This medication has minimal interactions with other diabetes treatments or some medications, but caution is needed as digoxin levels may slightly rise when taken together. It is important to consult a doctor or pharmacist immediately if any abnormal symptoms or side effects occur during use.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infections
  • nasopharyngitis
  • headache
  • diarrhea
Show 28 more
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute kidney injury
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and the storage temperature should maintain room temperature between 1 degree and 30 degrees. This will help to keep the drug's effectiveness safe for an extended period.

Appearance and packaging

Appearance

Pink, round, biconvex film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP×3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.